BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,881 | -22.0% | 129,323 | -5.9% | 2.30% | -15.3% |
| Q2 2023 | $6,258 | +28.8% | 137,365 | +14.7% | 2.72% | +5.6% |
| Q1 2023 | $4,858 | +8.3% | 119,770 | +36.1% | 2.58% | +4.2% |
| Q4 2022 | $4,485 | -99.9% | 88,001 | +4.7% | 2.47% | -7.2% |
| Q3 2022 | $4,525,000 | +1.1% | 84,023 | +20.6% | 2.66% | +8.0% |
| Q2 2022 | $4,475,000 | -9.6% | 69,668 | +9.1% | 2.46% | +6.0% |
| Q1 2022 | $4,950,000 | -14.2% | 63,833 | -5.0% | 2.32% | -12.6% |
| Q4 2021 | $5,767,000 | +133.8% | 67,183 | +119.0% | 2.66% | +115.8% |
| Q3 2021 | $2,467,000 | -37.4% | 30,675 | -37.4% | 1.23% | -35.7% |
| Q2 2021 | $3,942,000 | +93.5% | 48,970 | +6.6% | 1.92% | +592.1% |
| Q4 2016 | $2,037,000 | -31.0% | 45,943 | -25.9% | 0.28% | -35.3% |
| Q3 2016 | $2,952,000 | +1053.1% | 62,008 | +1586.4% | 0.43% | +773.5% |
| Q4 2013 | $256,000 | – | 3,677 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |